Trials / Recruiting
RecruitingNCT07284121
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
A Non-Interventional, Multicenter, Multicohort Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Subcutaneous Atezolizumab in Participants Treated in Routine Clinical Practice
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 700 (estimated)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a non-interventional, multi-country, multi-centre, multicohort, primary data collection study, designed to assess patients' reported satisfaction with Atezolizumab Subcutenous (SC) treatment and Health-related Quality of Life (HRQoL), as well as the effectiveness and safety of Atezolizumab SC in participants treated for selected approved indications in routine clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atezolizumab | Atezolizumab will be administered at the discretion of the treating physician and independently of participation in this study. |
Timeline
- Start date
- 2025-07-17
- Primary completion
- 2027-03-31
- Completion
- 2028-12-31
- First posted
- 2025-12-16
- Last updated
- 2026-03-27
Locations
86 sites across 8 countries: Austria, Belgium, Bulgaria, Italy, Poland, Romania, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT07284121. Inclusion in this directory is not an endorsement.